Global Solid-Phase Peptide Synthesis (SPPS) Service Market Growth (Status and Outlook) 2024-2030

Global Solid-Phase Peptide Synthesis (SPPS) Service Market Growth (Status and Outlook) 2024-2030

Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis. It can be defined as a process in which a peptide anchored by its c-terminus to an insoluble polymer is assembled by the successive addition of the protected amino acids constituting its sequence.

The global Solid-Phase Peptide Synthesis (SPPS) Service market size is projected to grow from US$ 149.7 million in 2023 to US$ 203.1 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Solid-Phase Peptide Synthesis (SPPS) Service Industry Forecast” looks at past sales and reviews total world Solid-Phase Peptide Synthesis (SPPS) Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Solid-Phase Peptide Synthesis (SPPS) Service sales for 2024 through 2030. With Solid-Phase Peptide Synthesis (SPPS) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid-Phase Peptide Synthesis (SPPS) Service industry.

This Insight Report provides a comprehensive analysis of the global Solid-Phase Peptide Synthesis (SPPS) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid-Phase Peptide Synthesis (SPPS) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid-Phase Peptide Synthesis (SPPS) Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid-Phase Peptide Synthesis (SPPS) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid-Phase Peptide Synthesis (SPPS) Service.

United States market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Solid-Phase Peptide Synthesis (SPPS) Service players cover Bachem, PolyPeptide, CordenPharma, AmbioPharm and USV Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Solid-Phase Peptide Synthesis (SPPS) Service market by product type, application, key players and key regions and countries.

Segmentation by type
GMP Services
Non-GMP Services

Segmentation by application
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec

Please note: The report will take approximately 2 business days to prepare and deliver.